SomaLogic Inc. Class A (SLGC)

$2.00

up-down-arrow $-0.20 (-9.09%)

As on 05-Jan-2024 18:22EDT

Market cap

info icon

$396 Mln

Revenue (TTM)

info icon

$82 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.8

Div. Yield

info icon

0 %

SomaLogic Inc. Class A (SLGC) Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: -- High: --

52 Week Range

Low: -- High: --

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $-108 Mln

  • ROEROE information

    -0.2 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    0.7

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-0.7

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    188,679,008

5 Years Aggregate

CFO

$-333.77 Mln

EBITDA

$-272.09 Mln

Net Profit

$-397.19 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
SomaLogic Inc. Class A (SLGC)
-20.9 -28.1 -3.4 -24.5 -- -- --
BSE Sensex*
-8.8 0.6 1.8 -4.4 6.0 6.6 10.8
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 05-Jan-2024  |  *As on 28-Aug-2026  |  #As on 26-Oct-2023
Company
2023
SomaLogic Inc. Class A (SLGC)
0.8
S&P Small-Cap 600
13.9
BSE Sensex
18.7

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
SomaLogic Inc. Class A (SLGC)
2.0 396.2 81.7 -130.4 -179.1 -25.3 -- 0.8
84.9 12,304.7 669.5 -320.0 -0.8 -71.1 -- 26.4
72.3 10,682.6 71.0 -894.0 -1,175.8 -- -- 60.3
54.2 13,400.0 2,435.9 860.6 31.0 43 17 7.3
105.3 12,277.1 1,663.7 413.6 36.3 430 31.2 83.9
350.5 10,258.4 440.5 241.5 33.4 18.7 42.2 7.3
534.5 11,938.8 1,283.9 -325.1 -19.0 -57.7 -- 22.9
603.9 17,326.2 2,782.3 491.5 21.1 110.1 36.5 39.4
348.4 10,496.2 0.0 -339.1 -- -30.6 -- 7.6
142.6 9,985.8 282.0 82.9 -28.6 11.4 147 11.6

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About SomaLogic Inc. Class A (SLGC)

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific...  for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado. 

  • Exec. Chairman

    Mr. Troy M. Cox M.B.A.

  • Exec. Chairman

    Mr. Troy M. Cox M.B.A.

  • Headquarters

    Boulder, CO

  • Website

    https://www.somalogic.com

FAQs for SomaLogic Inc. Class A (SLGC)

The share price of SomaLogic Inc Class A (SLGC) is $2.00 (NASDAQ) as of 05-Jan-2024 18:22 EDT. SomaLogic Inc Class A (SLGC) has given a return of -24.53% in the last 1 years.

Since, TTM earnings of SomaLogic Inc Class A (SLGC) is negative, P/E ratio is not available.
The P/B ratio of SomaLogic Inc Class A (SLGC) is 0.80 times as on 14-Aug-2026, a 85 discount to its peers’ median range of 5.35 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2022
-4.28
0.83
2021
-24.46
3.45
2020
--
--
2019
--
--
2022
-4.28
0.83

The 52-week high and low of SomaLogic Inc Class A (SLGC) are Rs -- and Rs -- as of 29-Aug-2026.

SomaLogic Inc Class A (SLGC) has a market capitalisation of $ 396 Mln as on 14-Aug-2026. As per SEBI classification, it is a Small Cap company.

Before investing in SomaLogic Inc Class A (SLGC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...